These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22908971)

  • 1. Association between inflammatory bowel disease gene 5 (IBD5) and interleukin-23 receptor (IL23R) genetic polymorphisms in Malaysian patients with Crohn's disease.
    Chua KH; Hilmi I; Lian LH; Patmanathan SN; Hoe SZ; Lee WS; Goh KL
    J Dig Dis; 2012 Sep; 13(9):459-65. PubMed ID: 22908971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients.
    Csöngei V; Járomi L; Sáfrány E; Sipeky C; Magyari L; Faragó B; Bene J; Polgár N; Lakner L; Sarlós P; Varga M; Melegh B
    World J Gastroenterol; 2010 Jan; 16(2):176-83. PubMed ID: 20066736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
    Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
    PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to ulcerative colitis in Hungarian patients determined by gene-gene interactions.
    Sarlos P; Varszegi D; Csongei V; Magyari L; Jaromi L; Nagy L; Melegh B
    World J Gastroenterol; 2014 Jan; 20(1):219-27. PubMed ID: 24415875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease.
    Russell RK; Drummond HE; Nimmo ER; Anderson NH; Noble CL; Wilson DC; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Satsangi J
    Gut; 2006 Aug; 55(8):1114-23. PubMed ID: 16469794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of IBD5 locus to clinical features of IBD patients.
    Latiano A; Palmieri O; Valvano RM; D'Incà R; Vecchi M; Ferraris A; Sturniolo GC; Spina L; Lombardi G; Dallapiccola B; Andriulli A; Devoto M; Annese V
    Am J Gastroenterol; 2006 Feb; 101(2):318-25. PubMed ID: 16454837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease.
    Tosa M; Negoro K; Kinouchi Y; Abe H; Nomura E; Takagi S; Aihara H; Oomori S; Sugimura M; Takahashi K; Hiwatashi N; Takahashi S; Shimosegawa T
    Scand J Gastroenterol; 2006 Jan; 41(1):48-53. PubMed ID: 16373276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DLG5 and SLC22A5 gene polymorphisms in Malaysian patients with Crohn's disease.
    Chua KH; Lian LH; Kee BP; Thum CM; Lee WS; Hilmi I; Goh KL
    J Dig Dis; 2011 Dec; 12(6):459-66. PubMed ID: 22118696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.
    Polgar N; Csongei V; Szabo M; Zambo V; Melegh BI; Sumegi K; Nagy G; Tulassay Z; Melegh B
    Int J Immunogenet; 2012 Jun; 39(3):247-52. PubMed ID: 22269120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
    Noble CL; Nimmo ER; Drummond H; Ho GT; Tenesa A; Smith L; Anderson N; Arnott ID; Satsangi J
    Gastroenterology; 2005 Dec; 129(6):1854-64. PubMed ID: 16344054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
    Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
    Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
    Okazaki T; Wang MH; Rawsthorne P; Sargent M; Datta LW; Shugart YY; Bernstein CN; Brant SR
    Inflamm Bowel Dis; 2008 Nov; 14(11):1528-41. PubMed ID: 18521914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease.
    Oliver J; Rueda B; López-Nevot MA; Gómez-García M; Martín J
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):977-81, 981.e1-2. PubMed ID: 17678845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children.
    Lacher M; Schroepf S; Helmbrecht J; Von Schweinitz D; Ballauff A; Koch I; Lohse P; Osterrieder S; Kappler R; Koletzko S
    Acta Paediatr; 2010 May; 99(5):727-733. PubMed ID: 20192940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
    Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.